A Closer Look at Sarcopenia
Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.
by Ashley P. Taylor
At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.
by Kevin McLaughlin
Immunotherapy Indications Withdrawn
In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
Cancer Did Not Cancel Our Plans
After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.
by Miriam Díaz-Gilbert
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
What Is Tumor Mutational Burden?
The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
Tumor Testing May Help Guide Pancreatic Cancer Treatment
For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.
by Cheryl Platzman Weinstock
Facing Cancer and a Pandemic at the Same Time
Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
Virtual Connection in a Time of Social Distance
Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
Nothing but Time
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.
by Adam P. Stern
The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.
by Eric FitzsimmonsAccelerating and Improving Drug Discovery
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
by Thomas CelonaAdvanced Care Planning Leads to More Comfort-based Care
Preparing for future health decisions helps ensure care is suited to your priorities.
by Karon WarrenDrop in Cancer Diagnoses Under COVID-19 Raises Alarms
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose